National Chapter Vision Webinar: Update on Emerging Therapies

The webinar provided reviews of several treatments in the clinical development pipeline including AGTC's gene therapy clinical trials for X-linked retinitis pigmentosa and achromatopsia; SparingVision's emerging cone-saving and cone-restoring treatments for retinitis pigmentosa, Usher syndrome, and related conditions; gene-agnostic approaches for a variety of conditions, clinical trials underway for Stargardt disease, and new emerging gene therapies for Leber congenital amaurosis.

Presenters included: 

Daniel Chung, DO, Chief Medical Officer, SparingVision
Bright Ashimatey, OD, PhD, FAAO, Clinical Research Scientist, AGTC
Claire Gelfman, PhD, Chief Scientific Officer, Foundation Fighting Blindness
Ben Shaberman, Senior Director, Scientific Outreach, Foundation Fighting Blindness

Видео National Chapter Vision Webinar: Update on Emerging Therapies канала Foundation Fighting Blindness